Pages

Saturday, June 12, 2010

Introduction to "Market-View"- The weekly investment newsletter by Sanjay Chhabria

"Market-View" is a complete and comprehensive weekly investment newsletter based on fundamentals which I am bringing since April 2001. MV is meant for medium-long term investors to help them take an informed investment decision It is sent on Sunday evening every week by email. It contains delivery based investment calls with buying and selling targets.

I advise people against F & 0/intraday trading/commodities as these are weapons of mass financial destruction- only concentrate on delivery based investment buying.
The way to make money from equities is to build a portfolio of good stocks and patiently hold on it. And by good stocks, I mean stocks of businesses with sound management and the potential to burgeon their earnings. But this requires an investor's time and inclination for good stock selection. Through my newsletter "Market-View" I help investors in stock selection and wealth creation. If you are a medium-long term investor, I would like you to send email to me at valueinv@sify.com to take trial copies of the newsletter.

Links of my latest articles on indianotes.com and interviews on CNBC-

My latest company report on indianotes.com on the links below- read and profit from it-
http://www.indianotes.com/author-details.php?cid=MzQw


My interview of 21st December on CNBC on the links below-
http://www.moneycontrol.com/news/stocks-views/gruh-finance-has-targetrs-350-sanjay-chabria_431942.html

24th November on CNBC on the links below-
http://www.moneycontrol.com/news/stocks-views/nagarjuna-agrichem-has-targetrs-350-chhabria_426885.html

31st August on CNBC on the links below-
http://www.moneycontrol.com/news/stocks-views/hanung-toys-has-targetrs-125-chhabria_413481.html

2 comments:

  1. Nice blog, for the traders trade in stocks. Can you provide MCX HNI Tips service.

    ReplyDelete
  2. Nifty Pharma index were also in green. Shares of Divi's LaboratoriesBSE 2.35 %, LupinBSE 1.22 %, Glenmark PharmaceuticalsBSE 0.21 % and Aurobindo PharmaBSE 4.52 % advanced between 0.75 per cent and 3 per cent. Equity tips


    ReplyDelete